Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 133-144 of 4,306
Drug study icon
RecruitingNCT07114874

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bryant
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Bulgaria, Romania, ...
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Device study icon
RecruitingNCT05580211

Neuromodulation for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
Canada
Sponsor
Scion NeuroStim
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT02455193

Neuronal Effects of Exercise in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Aurora
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 21 Years to 70 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Schizophrenia
Drug study icon
RecruitingNCT06021197

NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Taichung
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
Device study icon
RecruitingNCT06642675

nTMS for Negative Symptom in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Changsha
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceUp to 60 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
Device study icon
RecruitingNCT07176468

Personalized iTBS in Real-World Clinical Settings for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Hefei
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Anhui Medical University
Condition
Schizophrenia
Drug study icon
RecruitingNCT06961968

Withdrawal Study in people with Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Rogers
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT05184335

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Reviva Pharmaceuticals
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06361407

Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Marseille
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
France
Sponsor
Centre Psychothérapique de Nancy
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.